Development of targeted therapies for triple-negative breast cancer: can we harness tumor heterogeneity to improve patient outcomes?

Author： Diamond Jennifer R   Elias Anthony D  

Publisher： Future Medicine

ISSN： 1758-1923

Source： Breast Cancer Management, Vol.2, Iss.3, 2013-05, pp. : 175-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple-negative breast cancer: molecular characterization and targeted therapies

By Nicholson Allen   Bishop Jennifer   Lannin Donald   Killelea Brigid   Guo Xiaojia   Cha Charles   Dixon J Michael  

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 417-430

Future Medicine

Access to resources Recommend Favorite

Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer

By                      

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 163-171

Spandidos Publications

Access to resources Recommend Favorite

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

By Kruijf Esther  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 687-696

Springer Publishing Company

Access to resources Recommend Favorite

Imaging findings of triple-negative breast cancer

By Kawashima Hiroko  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 145-145

Springer Publishing Company

Access to resources Recommend Favorite

MR imaging of triple-negative breast cancer

By Uematsu Takayoshi  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 161-164

Springer Publishing Company

Access to resources Recommend Favorite